Virtus ETF Advisers LLC Assembly Biosciences, Inc. Transaction History

Virtus ETF Advisers LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.87 - $17.29 $71,881 - $255,200	-14,760 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$15.08 - $27.04 $30,401 - $54,512	-2,016 Reduced 12.02%	14,760 $243,000
Q2 2020 Aug 05, 2020	BUY	$14.57 - $23.96 $305 - $503	21 Added 0.13%	16,776 $391,000
Q1 2020 May 14, 2020	SELL	$10.27 - $21.23 $25,110 - $51,907	-2,445 Reduced 12.73%	16,755 $248,000
Q4 2019 Feb 13, 2020	BUY	$8.36 - $23.81 $14,621 - $41,643	1,749 Added 10.02%	19,200 $393,000
Q3 2019 Nov 12, 2019	SELL	$9.83 - $14.82 $9,525 - $14,360	-969 Reduced 5.26%	17,451 $172,000
Q2 2019 Aug 13, 2019	BUY	$12.9 - $20.8 $237,618 - $383,136	18,420 New	18,420 $248,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.